OQROStart free trial
Politician trade (House)

Abbott Laboratories (ABT): Rep. Josh Gottheimer (NJ05) disclosed a purchase $1K–$15K

Rep. Josh Gottheimer (NJ05) disclosed a purchase of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
21 days
Disclosure lag
Traded
Feb 13, 2025
Disclosed
Mar 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2024CongressDisclosed partial sale of ABT — reported range $15,001 - $50,000
  2. Dec 16, 2024CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  3. Jan 6, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  4. Jan 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  5. Jan 15, 2025Congress · 1 personMembers of Congress: 3 sales
  6. Jan 28, 2025InsiderOfficer sold ~$337K of ABT shares in the open market
  7. Jan 28, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  8. Jan 29, 2025InsiderOfficer sold ~$16.9M of ABT shares in the open market
  9. Jan 29, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  10. Jan 30, 2025Insider · 2 peopleInsiders: 2 sales (~$10.5M)
  11. Feb 5, 2025InsiderCEO sold ~$37.4M of ABT shares in the open market
  12. Feb 13, 2025 · this disclosureCongressDisclosed purchase of ABT — reported range $1,001 - $15,000

What came next

  1. Feb 24, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  2. Mar 3, 2025Insider · 5 peopleInsiders: 5 sales (~$549K)
  3. Mar 3, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  4. Mar 6, 2025InsiderOfficer sold ~$12.2M of ABT shares in the open market
  5. Mar 6, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  6. Mar 7, 2025InsiderOfficer sold ~$27K of ABT shares in the open market
  7. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-01 Software Version: All software versions Product Description: CELL-DYN Ruby…
  8. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-10 Software Version: All software versions Product Description: CELL-DYN Ruby…
  9. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-13 Software Version: All software versions Product Description: CELL-DYN Ruby…
  10. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 04U42-84 Software Version: All software versions Product Description: CELL-DYN Ruby
  11. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-03 Software Version: All software versions Product Description: CELL-DYN Ruby…
  12. Mar 20, 2025FDARecall: The Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers included in this recall are 08N53-001, 08N53-002, and 08N53-032…
  13. Mar 20, 2025Congress · 1 personMembers of Congress: 2 purchases
  14. Mar 24, 2025FDAFDA device clearance: Alinity m BKV
  15. Apr 4, 2025FDAFDA device clearance: JETi Hydrodynamic Thrombectomy System
  16. Apr 21, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  17. Apr 25, 2025FDAFDA device clearance: Amulet™ Steerable Delivery Sheath
  18. Apr 28, 2025FDARecall: Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the si…
  19. Apr 28, 2025FDARecall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) tes…
  20. Apr 30, 2025InsiderDirector sold ~$337K of ABT shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Josh Gottheimer (NJ05)

The full history of Rep. Josh Gottheimer (NJ05) is on the profile page.

How this filing works

Explore the data

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data